The SINPAIN research project, where Asphalion is the regulatory partner throughout, is on a mission to revolutionise the treatment of knee osteoarthritis by developing a novel nanomedicine-based therapeutic. A newly released video clip explores the project’s innovative approach and the potentially life-changing benefits for individuals affected by the debilitating joint disorder.
The animated video offers a comprehensive overview of the novel techniques and methodologies being developed by SINPAIN. This includes advanced therapy based on small interfering RNA (siRNA), the latest intraarticular hyaluronic acid (IA-HA) and nanocarrier technologies, and state-of-the-art machine learning methods.
The clip demonstrates how these advancements could alleviate the pain and discomfort associated with knee osteoarthritis, and underscores the potential of the project’s research to reshape the future of osteoarthritis treatment. The video is now available for viewing on the SINPAIN project website. For the latest updates about the work conducted in the project, please follow SINPAIN on LinkedIn.
For further information you can contact us at: [email protected]